Replies to post #448989 on Anavex Life Sciences Corp (AVXL)

[Hosai]

Avatars end point wasn't changed, the company said to go with their prior prs not that third party website which isn't mandatory and isn't always fast to update.
As a case in point with the Excellence trial on the clinical trials website the CGI end point was a secondary not primary as the company reported so would have actually made them look better.
Therefore if you're going to argue they changed their end points for avatar because the clinical trials site is all that matters then you also have to concede Excellence wasn't so bad and only a very narror miss of p=0.63% on the only primary end point (obv on a study where our placebo group performed better than Daybues drug group - a group of whom would have had large non-placebo signals due to the drug causing diarreah in most of the patients.)